Core Viewpoint - Sanfu Xinke (688359) reported disappointing performance in the first half of 2025, continuing a trend of losses for three consecutive years, with a net profit of approximately -22.31 million yuan, indicating an increase in losses compared to the previous year [1][4]. Financial Performance - In the first half of 2025, the company achieved operating revenue of approximately 227 million yuan, a year-on-year decrease of 23.26% [1]. - The net profit attributable to shareholders was approximately -22.31 million yuan, reflecting an increase in losses year-on-year [1]. - The net profit after deducting non-recurring items was approximately -24.40 million yuan, also showing an increase in losses compared to the previous year [1]. - The company attributed the increased losses to a significant decline in equipment component revenue and a drop in gross profit from equipment sales, as well as the absence of investment income from the previous year when a subsidiary's equity was transferred [1][4]. Research and Development - Research and development expenses for the first half of 2025 were approximately 32.90 million yuan, a decrease of 12.71% year-on-year [2]. - The proportion of R&D expenses to operating revenue increased from 12.73% in the previous year to 14.48% in the current year, an increase of 1.75 percentage points [2]. - As of the end of the reporting period, the company held a total of 91 invention patents and 97 utility model patents [2]. Sales and Marketing - Sales expenses for the first half of 2025 were approximately 30.75 million yuan, representing a year-on-year increase of 26.28% [2]. Financial Position - As of the end of the first half of 2025, the company had cash and cash equivalents of approximately 64.87 million yuan, an increase of 49.63% year-on-year, attributed to increased funds from stock option exercises [2]. - The company had short-term borrowings of approximately 134 million yuan, a decrease of 46.56% compared to the end of the previous year, while long-term borrowings were approximately 115 million yuan, an increase of 263.42% [2]. Market Performance - On August 26, 2025, the company's stock opened down 1.89% but later rose, reaching a high of 75.5 yuan per share, marking a 14% increase during the day and closing with a gain of 10.46% at 73.2 yuan per share, with a total market capitalization of 7.156 billion yuan [5]. - Over the 55 trading days from June 11 to August 26, 2025, the company's stock price increased by 53.17%, significantly outperforming the broader market, which rose by 14.29% during the same period [5].
中报亏出上市后新高,三孚新科业绩走下坡路